• Like
  • Comment
  • Favorite

Perfect Optronics Sees Decrease in Revenue of Group for FY2024

THOMSON REUTERS03-11

Perfect Optronics Sees Decrease in Revenue of Group for FY2024

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
errorbox banner

抱歉,当前请求异常(-1)

7x24

  • 20:42

    Medpace Holdings Inc - Amendment No. 7 Extends Revolving Credit Note to March 31, 2026 - SEC Filing

  • 20:42

    Medpace Holdings - Co Units Entered Amendment No. 7 to Loan Documents With PNC Bank - SEC Filing

  • 20:40

    Adverum Biotechnologies Inc - Company Expects to Report at Least One Material Weakness - SEC Filing

  • 20:40

    Adverum Biotechnologies Inc - Some Prior Financial Statements Should No Longer Be Relied Upon - SEC Filing

  • 20:39

    Repare Therapeutics: Lloyd M. Segal Resigned as President, CEO and Director

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial